Omega Healthcare Investors (OHI) PT Lowered to $46 at Truist Securities

Truist Securities analyst Michael Lewis lowered the price target on Omega Healthcare Investors (NYSE: OHI) to $46.00 (from $48.00) while maintaining a Hold rating.

The analyst comments "Lowering Price Target: Despite our higher near-term FFO estimates, we are trimming our 12-month price target to $46 from $48ps, based on a $47.49 discounted cash flow (one-third weighting), a 35% assumed premium to our projected NAV a year from now (one third) and 14.0x 2027E FFOps. OHI currently trades at a 35% premium to our NAV estimate versus a 25% average premium over the past five years, and at 14.0x 2026 FFO versus an 11.7x historical average. Our previous price target was based on a $47.96 DCF, a 45% assumed premium to our estimate of NAV one year forward, and a 15.3x target FFO multiple."

You May Also Be Interested In

• ACM Research, Inc. (ACMR) PT Raised to $130 at Morgan Stanley
• Cytokinetics (CYTK) PT Raised to $118 at Mizuho
• Southwest (LUV) PT Raised to $61 at UBS Ahead of Q2 Print